U.S. markets close in 5 hours 13 minutes
  • S&P 500

    4,240.33
    -43.41 (-1.01%)
     
  • Dow 30

    33,788.60
    -210.44 (-0.62%)
     
  • Nasdaq

    12,749.49
    -215.85 (-1.66%)
     
  • Russell 2000

    1,964.32
    -36.41 (-1.82%)
     
  • Crude Oil

    91.13
    +0.63 (+0.70%)
     
  • Gold

    1,759.80
    -11.40 (-0.64%)
     
  • Silver

    18.93
    -0.53 (-2.74%)
     
  • EUR/USD

    1.0048
    -0.0044 (-0.43%)
     
  • 10-Yr Bond

    2.9830
    +0.1030 (+3.58%)
     
  • GBP/USD

    1.1807
    -0.0126 (-1.06%)
     
  • USD/JPY

    137.1800
    +1.3180 (+0.97%)
     
  • BTC-USD

    21,421.22
    -2,033.13 (-8.67%)
     
  • CMC Crypto 200

    508.60
    -33.00 (-6.09%)
     
  • FTSE 100

    7,562.75
    +20.90 (+0.28%)
     
  • Nikkei 225

    28,930.33
    -11.81 (-0.04%)
     

Did Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Insiders Buy Up More Shares?

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be remiss not to mention that insider sales have been known to precede tough periods for a business. So before you buy or sell Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI), you may well want to know whether insiders have been buying or selling.

Do Insider Transactions Matter?

It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most countries require that the company discloses such transactions to the market.

We don't think shareholders should simply follow insider transactions. But logic dictates you should pay some attention to whether insiders are buying or selling shares. As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise'.

See our latest analysis for Brainstorm Cell Therapeutics

Brainstorm Cell Therapeutics Insider Transactions Over The Last Year

The Executive VP & COO David Setboun made the biggest insider purchase in the last 12 months. That single transaction was for US$65k worth of shares at a price of US$12.95 each. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$3.62). While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. The only individual insider to buy over the last year was David Setboun.

The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Does Brainstorm Cell Therapeutics Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 5.5% of Brainstorm Cell Therapeutics shares, worth about US$7.3m, according to our data. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. We do generally prefer see higher levels of insider ownership.

So What Do The Brainstorm Cell Therapeutics Insider Transactions Indicate?

There haven't been any insider transactions in the last three months -- that doesn't mean much. On a brighter note, the transactions over the last year are encouraging. While we have no worries about the insider transactions, we'd be more comfortable if they owned more Brainstorm Cell Therapeutics stock. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. Every company has risks, and we've spotted 1 warning sign for Brainstorm Cell Therapeutics you should know about.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.